▶ 調査レポート

GMPインターロイキンのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global GMP Interleukin Market Insights and Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。GMPインターロイキンのグローバル市場インサイト・予測(~2028年) / Global GMP Interleukin Market Insights and Forecast to 2028 / QY2203B00624資料のイメージです。• レポートコード:QY2203B00624
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥686,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,029,000 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,372,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のGMPインターロイキンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にGMPインターロイキンの世界市場のxxx%を占める「25μg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「細胞・遺伝子治療」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のGMPインターロイキンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのGMPインターロイキン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのGMPインターロイキン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

GMPインターロイキンのグローバル主要メーカーには、Miltenyi Biotec、Bio-Techne、GE Healthcare、Lonza、CellGenix、ReproCELL、PeproTech、Sino Biological、Creative Bioarray、Akron Biotech、Almogなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

GMPインターロイキン市場は、種類と用途によって区分されます。世界のGMPインターロイキン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
25μg、50μg、その他

【用途別セグメント】
細胞・遺伝子治療、組織工学製品、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- GMPインターロイキン製品概要
- 種類別市場(25μg、50μg、その他)
- 用途別市場(細胞・遺伝子治療、組織工学製品、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のGMPインターロイキン販売量予測2017-2028
- 世界のGMPインターロイキン売上予測2017-2028
- GMPインターロイキンの地域別販売量
- GMPインターロイキンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別GMPインターロイキン販売量
- 主要メーカー別GMPインターロイキン売上
- 主要メーカー別GMPインターロイキン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(25μg、50μg、その他)
- GMPインターロイキンの種類別販売量
- GMPインターロイキンの種類別売上
- GMPインターロイキンの種類別価格
・用途別市場規模(細胞・遺伝子治療、組織工学製品、その他)
- GMPインターロイキンの用途別販売量
- GMPインターロイキンの用途別売上
- GMPインターロイキンの用途別価格
・北米市場
- 北米のGMPインターロイキン市場規模(種類別、用途別)
- 主要国別のGMPインターロイキン市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのGMPインターロイキン市場規模(種類別、用途別)
- 主要国別のGMPインターロイキン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のGMPインターロイキン市場規模(種類別、用途別)
- 主要国別のGMPインターロイキン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のGMPインターロイキン市場規模(種類別、用途別)
- 主要国別のGMPインターロイキン市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのGMPインターロイキン市場規模(種類別、用途別)
- 主要国別のGMPインターロイキン市場規模(トルコ、サウジアラビア)
・企業情報
Miltenyi Biotec、Bio-Techne、GE Healthcare、Lonza、CellGenix、ReproCELL、PeproTech、Sino Biological、Creative Bioarray、Akron Biotech、Almog
・産業チェーン及び販売チャネル分析
- GMPインターロイキンの産業チェーン分析
- GMPインターロイキンの原材料
- GMPインターロイキンの生産プロセス
- GMPインターロイキンの販売及びマーケティング
- GMPインターロイキンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- GMPインターロイキンの産業動向
- GMPインターロイキンのマーケットドライバー
- GMPインターロイキンの課題
- GMPインターロイキンの阻害要因
・主な調査結果

Interleukins are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes).
Market Analysis and Insights: Global GMP Interleukin Market
Due to the COVID-19 pandemic, the global GMP Interleukin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 25μg accounting for % of the GMP Interleukin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cell/Gene Therapy segment is altered to an % CAGR throughout this forecast period.
China GMP Interleukin market size is valued at US$ million in 2021, while the US and Europe GMP Interleukin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe GMP Interleukin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of GMP Interleukin include Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological and Creative Bioarray, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global GMP Interleukin Scope and Segment
GMP Interleukin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global GMP Interleukin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
25μg
50μg
Others
Segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others
By Company
Miltenyi Biotec
Bio-Techne
GE Healthcare
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 GMP Interleukin Product Introduction
1.2 Market by Type
1.2.1 Global GMP Interleukin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 25μg
1.2.3 50μg
1.2.4 Others
1.3 Market by Application
1.3.1 Global GMP Interleukin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cell/Gene Therapy
1.3.3 Tissue-Engineered Products
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global GMP Interleukin Sales Estimates and Forecasts 2017-2028
2.2 Global GMP Interleukin Revenue Estimates and Forecasts 2017-2028
2.3 Global GMP Interleukin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global GMP Interleukin Sales by Region
2.4.1 Global GMP Interleukin Sales by Region (2017-2022)
2.4.2 Global Sales GMP Interleukin by Region (2023-2028)
2.5 Global GMP Interleukin Revenue by Region
2.5.1 Global GMP Interleukin Revenue by Region (2017-2022)
2.5.2 Global GMP Interleukin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global GMP Interleukin Sales by Manufacturers
3.1.1 Global Top GMP Interleukin Manufacturers by Sales (2017-2022)
3.1.2 Global GMP Interleukin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GMP Interleukin in 2021
3.2 Global GMP Interleukin Revenue by Manufacturers
3.2.1 Global GMP Interleukin Revenue by Manufacturers (2017-2022)
3.2.2 Global GMP Interleukin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by GMP Interleukin Revenue in 2021
3.3 Global GMP Interleukin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global GMP Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global GMP Interleukin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GMP Interleukin Sales by Type
4.1.1 Global GMP Interleukin Historical Sales by Type (2017-2022)
4.1.2 Global GMP Interleukin Forecasted Sales by Type (2023-2028)
4.1.3 Global GMP Interleukin Sales Market Share by Type (2017-2028)
4.2 Global GMP Interleukin Revenue by Type
4.2.1 Global GMP Interleukin Historical Revenue by Type (2017-2022)
4.2.2 Global GMP Interleukin Forecasted Revenue by Type (2023-2028)
4.2.3 Global GMP Interleukin Revenue Market Share by Type (2017-2028)
4.3 Global GMP Interleukin Price by Type
4.3.1 Global GMP Interleukin Price by Type (2017-2022)
4.3.2 Global GMP Interleukin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global GMP Interleukin Sales by Application
5.1.1 Global GMP Interleukin Historical Sales by Application (2017-2022)
5.1.2 Global GMP Interleukin Forecasted Sales by Application (2023-2028)
5.1.3 Global GMP Interleukin Sales Market Share by Application (2017-2028)
5.2 Global GMP Interleukin Revenue by Application
5.2.1 Global GMP Interleukin Historical Revenue by Application (2017-2022)
5.2.2 Global GMP Interleukin Forecasted Revenue by Application (2023-2028)
5.2.3 Global GMP Interleukin Revenue Market Share by Application (2017-2028)
5.3 Global GMP Interleukin Price by Application
5.3.1 Global GMP Interleukin Price by Application (2017-2022)
5.3.2 Global GMP Interleukin Price Forecast by Application (2023-2028)
6 North America
6.1 North America GMP Interleukin Market Size by Type
6.1.1 North America GMP Interleukin Sales by Type (2017-2028)
6.1.2 North America GMP Interleukin Revenue by Type (2017-2028)
6.2 North America GMP Interleukin Market Size by Application
6.2.1 North America GMP Interleukin Sales by Application (2017-2028)
6.2.2 North America GMP Interleukin Revenue by Application (2017-2028)
6.3 North America GMP Interleukin Market Size by Country
6.3.1 North America GMP Interleukin Sales by Country (2017-2028)
6.3.2 North America GMP Interleukin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe GMP Interleukin Market Size by Type
7.1.1 Europe GMP Interleukin Sales by Type (2017-2028)
7.1.2 Europe GMP Interleukin Revenue by Type (2017-2028)
7.2 Europe GMP Interleukin Market Size by Application
7.2.1 Europe GMP Interleukin Sales by Application (2017-2028)
7.2.2 Europe GMP Interleukin Revenue by Application (2017-2028)
7.3 Europe GMP Interleukin Market Size by Country
7.3.1 Europe GMP Interleukin Sales by Country (2017-2028)
7.3.2 Europe GMP Interleukin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific GMP Interleukin Market Size by Type
8.1.1 Asia Pacific GMP Interleukin Sales by Type (2017-2028)
8.1.2 Asia Pacific GMP Interleukin Revenue by Type (2017-2028)
8.2 Asia Pacific GMP Interleukin Market Size by Application
8.2.1 Asia Pacific GMP Interleukin Sales by Application (2017-2028)
8.2.2 Asia Pacific GMP Interleukin Revenue by Application (2017-2028)
8.3 Asia Pacific GMP Interleukin Market Size by Region
8.3.1 Asia Pacific GMP Interleukin Sales by Region (2017-2028)
8.3.2 Asia Pacific GMP Interleukin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America GMP Interleukin Market Size by Type
9.1.1 Latin America GMP Interleukin Sales by Type (2017-2028)
9.1.2 Latin America GMP Interleukin Revenue by Type (2017-2028)
9.2 Latin America GMP Interleukin Market Size by Application
9.2.1 Latin America GMP Interleukin Sales by Application (2017-2028)
9.2.2 Latin America GMP Interleukin Revenue by Application (2017-2028)
9.3 Latin America GMP Interleukin Market Size by Country
9.3.1 Latin America GMP Interleukin Sales by Country (2017-2028)
9.3.2 Latin America GMP Interleukin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa GMP Interleukin Market Size by Type
10.1.1 Middle East and Africa GMP Interleukin Sales by Type (2017-2028)
10.1.2 Middle East and Africa GMP Interleukin Revenue by Type (2017-2028)
10.2 Middle East and Africa GMP Interleukin Market Size by Application
10.2.1 Middle East and Africa GMP Interleukin Sales by Application (2017-2028)
10.2.2 Middle East and Africa GMP Interleukin Revenue by Application (2017-2028)
10.3 Middle East and Africa GMP Interleukin Market Size by Country
10.3.1 Middle East and Africa GMP Interleukin Sales by Country (2017-2028)
10.3.2 Middle East and Africa GMP Interleukin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Miltenyi Biotec
11.1.1 Miltenyi Biotec Corporation Information
11.1.2 Miltenyi Biotec Overview
11.1.3 Miltenyi Biotec GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Miltenyi Biotec GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Miltenyi Biotec Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Corporation Information
11.2.2 Bio-Techne Overview
11.2.3 Bio-Techne GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bio-Techne GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bio-Techne Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Corporation Information
11.3.2 GE Healthcare Overview
11.3.3 GE Healthcare GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GE Healthcare GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GE Healthcare Recent Developments
11.4 Lonza
11.4.1 Lonza Corporation Information
11.4.2 Lonza Overview
11.4.3 Lonza GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lonza GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lonza Recent Developments
11.5 CellGenix
11.5.1 CellGenix Corporation Information
11.5.2 CellGenix Overview
11.5.3 CellGenix GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CellGenix GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CellGenix Recent Developments
11.6 ReproCELL
11.6.1 ReproCELL Corporation Information
11.6.2 ReproCELL Overview
11.6.3 ReproCELL GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 ReproCELL GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ReproCELL Recent Developments
11.7 PeproTech
11.7.1 PeproTech Corporation Information
11.7.2 PeproTech Overview
11.7.3 PeproTech GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PeproTech GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PeproTech Recent Developments
11.8 Sino Biological
11.8.1 Sino Biological Corporation Information
11.8.2 Sino Biological Overview
11.8.3 Sino Biological GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sino Biological GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sino Biological Recent Developments
11.9 Creative Bioarray
11.9.1 Creative Bioarray Corporation Information
11.9.2 Creative Bioarray Overview
11.9.3 Creative Bioarray GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Creative Bioarray GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Creative Bioarray Recent Developments
11.10 Akron Biotech
11.10.1 Akron Biotech Corporation Information
11.10.2 Akron Biotech Overview
11.10.3 Akron Biotech GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Akron Biotech GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Akron Biotech Recent Developments
11.11 Almog
11.11.1 Almog Corporation Information
11.11.2 Almog Overview
11.11.3 Almog GMP Interleukin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Almog GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Almog Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GMP Interleukin Industry Chain Analysis
12.2 GMP Interleukin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GMP Interleukin Production Mode & Process
12.4 GMP Interleukin Sales and Marketing
12.4.1 GMP Interleukin Sales Channels
12.4.2 GMP Interleukin Distributors
12.5 GMP Interleukin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 GMP Interleukin Industry Trends
13.2 GMP Interleukin Market Drivers
13.3 GMP Interleukin Market Challenges
13.4 GMP Interleukin Market Restraints
14 Key Findings in The Global GMP Interleukin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global GMP Interleukin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 25μg
Table 3. Major Manufacturers of 50μg
Table 4. Major Manufacturers of Others
Table 5. Global GMP Interleukin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global GMP Interleukin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global GMP Interleukin Sales by Region (2017-2022) & (K Units)
Table 8. Global GMP Interleukin Sales Market Share by Region (2017-2022)
Table 9. Global GMP Interleukin Sales by Region (2023-2028) & (K Units)
Table 10. Global GMP Interleukin Sales Market Share by Region (2023-2028)
Table 11. Global GMP Interleukin Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global GMP Interleukin Revenue Market Share by Region (2017-2022)
Table 13. Global GMP Interleukin Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global GMP Interleukin Revenue Market Share by Region (2023-2028)
Table 15. Global GMP Interleukin Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global GMP Interleukin Sales Share by Manufacturers (2017-2022)
Table 17. Global GMP Interleukin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global GMP Interleukin Revenue Share by Manufacturers (2017-2022)
Table 19. GMP Interleukin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global GMP Interleukin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global GMP Interleukin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Interleukin as of 2021)
Table 22. GMP Interleukin Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers GMP Interleukin Product Offered
Table 24. Date of Manufacturers Enter into GMP Interleukin Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global GMP Interleukin Sales by Type (2017-2022) & (K Units)
Table 27. Global GMP Interleukin Sales by Type (2023-2028) & (K Units)
Table 28. Global GMP Interleukin Sales Share by Type (2017-2022)
Table 29. Global GMP Interleukin Sales Share by Type (2023-2028)
Table 30. Global GMP Interleukin Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global GMP Interleukin Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global GMP Interleukin Revenue Share by Type (2017-2022)
Table 33. Global GMP Interleukin Revenue Share by Type (2023-2028)
Table 34. GMP Interleukin Price by Type (2017-2022) & (US$/Unit)
Table 35. Global GMP Interleukin Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global GMP Interleukin Sales by Application (2017-2022) & (K Units)
Table 37. Global GMP Interleukin Sales by Application (2023-2028) & (K Units)
Table 38. Global GMP Interleukin Sales Share by Application (2017-2022)
Table 39. Global GMP Interleukin Sales Share by Application (2023-2028)
Table 40. Global GMP Interleukin Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global GMP Interleukin Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global GMP Interleukin Revenue Share by Application (2017-2022)
Table 43. Global GMP Interleukin Revenue Share by Application (2023-2028)
Table 44. GMP Interleukin Price by Application (2017-2022) & (US$/Unit)
Table 45. Global GMP Interleukin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America GMP Interleukin Sales by Type (2017-2022) & (K Units)
Table 47. North America GMP Interleukin Sales by Type (2023-2028) & (K Units)
Table 48. North America GMP Interleukin Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America GMP Interleukin Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America GMP Interleukin Sales by Application (2017-2022) & (K Units)
Table 51. North America GMP Interleukin Sales by Application (2023-2028) & (K Units)
Table 52. North America GMP Interleukin Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America GMP Interleukin Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America GMP Interleukin Sales by Country (2017-2022) & (K Units)
Table 55. North America GMP Interleukin Sales by Country (2023-2028) & (K Units)
Table 56. North America GMP Interleukin Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America GMP Interleukin Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe GMP Interleukin Sales by Type (2017-2022) & (K Units)
Table 59. Europe GMP Interleukin Sales by Type (2023-2028) & (K Units)
Table 60. Europe GMP Interleukin Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe GMP Interleukin Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe GMP Interleukin Sales by Application (2017-2022) & (K Units)
Table 63. Europe GMP Interleukin Sales by Application (2023-2028) & (K Units)
Table 64. Europe GMP Interleukin Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe GMP Interleukin Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe GMP Interleukin Sales by Country (2017-2022) & (K Units)
Table 67. Europe GMP Interleukin Sales by Country (2023-2028) & (K Units)
Table 68. Europe GMP Interleukin Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe GMP Interleukin Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific GMP Interleukin Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific GMP Interleukin Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific GMP Interleukin Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific GMP Interleukin Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific GMP Interleukin Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific GMP Interleukin Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific GMP Interleukin Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific GMP Interleukin Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific GMP Interleukin Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific GMP Interleukin Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific GMP Interleukin Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific GMP Interleukin Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America GMP Interleukin Sales by Type (2017-2022) & (K Units)
Table 83. Latin America GMP Interleukin Sales by Type (2023-2028) & (K Units)
Table 84. Latin America GMP Interleukin Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America GMP Interleukin Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America GMP Interleukin Sales by Application (2017-2022) & (K Units)
Table 87. Latin America GMP Interleukin Sales by Application (2023-2028) & (K Units)
Table 88. Latin America GMP Interleukin Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America GMP Interleukin Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America GMP Interleukin Sales by Country (2017-2022) & (K Units)
Table 91. Latin America GMP Interleukin Sales by Country (2023-2028) & (K Units)
Table 92. Latin America GMP Interleukin Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America GMP Interleukin Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa GMP Interleukin Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa GMP Interleukin Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa GMP Interleukin Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa GMP Interleukin Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa GMP Interleukin Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa GMP Interleukin Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa GMP Interleukin Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa GMP Interleukin Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa GMP Interleukin Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa GMP Interleukin Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa GMP Interleukin Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa GMP Interleukin Revenue by Country (2023-2028) & (US$ Million)
Table 106. Miltenyi Biotec Corporation Information
Table 107. Miltenyi Biotec Description and Major Businesses
Table 108. Miltenyi Biotec GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Miltenyi Biotec GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Miltenyi Biotec Recent Developments
Table 111. Bio-Techne Corporation Information
Table 112. Bio-Techne Description and Major Businesses
Table 113. Bio-Techne GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Bio-Techne GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Bio-Techne Recent Developments
Table 116. GE Healthcare Corporation Information
Table 117. GE Healthcare Description and Major Businesses
Table 118. GE Healthcare GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. GE Healthcare GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GE Healthcare Recent Developments
Table 121. Lonza Corporation Information
Table 122. Lonza Description and Major Businesses
Table 123. Lonza GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Lonza GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lonza Recent Developments
Table 126. CellGenix Corporation Information
Table 127. CellGenix Description and Major Businesses
Table 128. CellGenix GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. CellGenix GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. CellGenix Recent Developments
Table 131. ReproCELL Corporation Information
Table 132. ReproCELL Description and Major Businesses
Table 133. ReproCELL GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. ReproCELL GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. ReproCELL Recent Developments
Table 136. PeproTech Corporation Information
Table 137. PeproTech Description and Major Businesses
Table 138. PeproTech GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. PeproTech GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. PeproTech Recent Developments
Table 141. Sino Biological Corporation Information
Table 142. Sino Biological Description and Major Businesses
Table 143. Sino Biological GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Sino Biological GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sino Biological Recent Developments
Table 146. Creative Bioarray Corporation Information
Table 147. Creative Bioarray Description and Major Businesses
Table 148. Creative Bioarray GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Creative Bioarray GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Creative Bioarray Recent Developments
Table 151. Akron Biotech Corporation Information
Table 152. Akron Biotech Description and Major Businesses
Table 153. Akron Biotech GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Akron Biotech GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Akron Biotech Recent Developments
Table 156. Almog Corporation Information
Table 157. Almog Description and Major Businesses
Table 158. Almog GMP Interleukin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Almog GMP Interleukin Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Almog Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. GMP Interleukin Distributors List
Table 164. GMP Interleukin Customers List
Table 165. GMP Interleukin Market Trends
Table 166. GMP Interleukin Market Drivers
Table 167. GMP Interleukin Market Challenges
Table 168. GMP Interleukin Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. GMP Interleukin Product Picture
Figure 3. Global GMP Interleukin Market Share by Type in 2021 & 2028
Figure 3. 25μg Product Picture
Figure 4. 50μg Product Picture
Figure 5. Others Product Picture
Figure 6. Global GMP Interleukin Market Share by Application in 2021 & 2028
Figure 7. Cell/Gene Therapy
Figure 8. Tissue-Engineered Products
Figure 9. Others
Figure 10. GMP Interleukin Report Years Considered
Figure 11. Global GMP Interleukin Sales 2017-2028 (K Units)
Figure 12. Global GMP Interleukin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global GMP Interleukin Revenue 2017-2028 (US$ Million)
Figure 14. Global GMP Interleukin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global GMP Interleukin Sales Market Share by Region (2017-2022)
Figure 16. Global GMP Interleukin Sales Market Share by Region (2023-2028)
Figure 17. North America GMP Interleukin Sales YoY (2017-2028) & (K Units)
Figure 18. North America GMP Interleukin Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe GMP Interleukin Sales YoY (2017-2028) & (K Units)
Figure 20. Europe GMP Interleukin Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific GMP Interleukin Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific GMP Interleukin Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America GMP Interleukin Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America GMP Interleukin Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa GMP Interleukin Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa GMP Interleukin Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The GMP Interleukin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of GMP Interleukin in the World: Market Share by GMP Interleukin Revenue in 2021
Figure 29. Global GMP Interleukin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global GMP Interleukin Sales Market Share by Type (2017-2028)
Figure 31. Global GMP Interleukin Revenue Market Share by Type (2017-2028)
Figure 32. Global GMP Interleukin Sales Market Share by Application (2017-2028)
Figure 33. Global GMP Interleukin Revenue Market Share by Application (2017-2028)
Figure 34. North America GMP Interleukin Sales Market Share by Type (2017-2028)
Figure 35. North America GMP Interleukin Revenue Market Share by Type (2017-2028)
Figure 36. North America GMP Interleukin Sales Market Share by Application (2017-2028)
Figure 37. North America GMP Interleukin Revenue Market Share by Application (2017-2028)
Figure 38. North America GMP Interleukin Sales Share by Country (2017-2028)
Figure 39. North America GMP Interleukin Revenue Share by Country (2017-2028)
Figure 40. U.S. GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 41. Canada GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 42. Europe GMP Interleukin Sales Market Share by Type (2017-2028)
Figure 43. Europe GMP Interleukin Revenue Market Share by Type (2017-2028)
Figure 44. Europe GMP Interleukin Sales Market Share by Application (2017-2028)
Figure 45. Europe GMP Interleukin Revenue Market Share by Application (2017-2028)
Figure 46. Europe GMP Interleukin Sales Share by Country (2017-2028)
Figure 47. Europe GMP Interleukin Revenue Share by Country (2017-2028)
Figure 48. Germany GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 49. France GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 51. Italy GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 52. Russia GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific GMP Interleukin Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific GMP Interleukin Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific GMP Interleukin Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific GMP Interleukin Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific GMP Interleukin Sales Share by Region (2017-2028)
Figure 58. Asia Pacific GMP Interleukin Revenue Share by Region (2017-2028)
Figure 59. China GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 60. Japan GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 62. India GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 63. Australia GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America GMP Interleukin Sales Market Share by Type (2017-2028)
Figure 70. Latin America GMP Interleukin Revenue Market Share by Type (2017-2028)
Figure 71. Latin America GMP Interleukin Sales Market Share by Application (2017-2028)
Figure 72. Latin America GMP Interleukin Revenue Market Share by Application (2017-2028)
Figure 73. Latin America GMP Interleukin Sales Share by Country (2017-2028)
Figure 74. Latin America GMP Interleukin Revenue Share by Country (2017-2028)
Figure 75. Mexico GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa GMP Interleukin Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa GMP Interleukin Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa GMP Interleukin Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa GMP Interleukin Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa GMP Interleukin Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa GMP Interleukin Revenue Share by Country (2017-2028)
Figure 84. Turkey GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 86. UAE GMP Interleukin Revenue (2017-2028) & (US$ Million)
Figure 87. GMP Interleukin Value Chain
Figure 88. GMP Interleukin Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed